Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mesoblast Ltd ADR (MESO)

Mesoblast Ltd ADR (MESO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 818,656
  • Shares Outstanding, K 114,178
  • Annual Sales, $ 7,500 K
  • Annual Income, $ -81,890 K
  • 60-Month Beta 3.45
  • Price/Sales 115.53
  • Price/Cash Flow N/A
  • Price/Book 1.59
Trade MESO with:

Options Overview Details

View History
  • Implied Volatility 65.23% ( -87.05%)
  • Historical Volatility 104.92%
  • IV Percentile 19%
  • IV Rank 7.90%
  • IV High 580.80% on 08/11/23
  • IV Low 21.04% on 10/26/23
  • Put/Call Vol Ratio 0.33
  • Today's Volume 142
  • Volume Avg (30-Day) 910
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 24,977
  • Open Int (30-Day) 21,922

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +384,330.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.60 +60.00%
on 04/17/24
8.46 -13.00%
on 05/06/24
+1.56 (+26.90%)
since 04/10/24
3-Month
1.81 +306.63%
on 02/13/24
8.46 -13.00%
on 05/06/24
+5.54 (+304.40%)
since 02/09/24
52-Week
1.61 +357.14%
on 01/18/24
10.24 -28.12%
on 07/17/23
-0.20 (-2.65%)
since 05/10/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesoblast Limited - MESO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mesoblast Limited ("Mesoblast" or the "Company") (NASDAQ: MESO). Such investors...

MESO : 7.36 (+2.65%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesoblast Limited - MESO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mesoblast Limited ("Mesoblast" or the "Company") (NASDAQ: MESO). Such investors...

MESO : 7.36 (+2.65%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesoblast Limited - MESO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mesoblast Limited ("Mesoblast" or the "Company") (NASDAQ: MESO). Such investors...

MESO : 7.36 (+2.65%)
Why Shares of Mesoblast Are Down Monday

The company's shares continued to tumble after it received a Complete Response Letter last week from the FDA.

MSB.AX : 1.065 (-2.29%)
MESO : 7.36 (+2.65%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesoblast Limited - MESO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mesoblast Limited ("Mesoblast" or the "Company") (NASDAQ: MESO). Such investors...

MESO : 7.36 (+2.65%)
Why Shares of Mesoblast Are Plunging Friday

The company received a Complete Response Letter from the FDA regarding its prospective graft-versus-host disease therapy.

MSB.AX : 1.065 (-2.29%)
MESO : 7.36 (+2.65%)
Mesoblast's (MESO) GVHD Drug BLA Gets FDA Priority Tag, Stock Up

Mesoblast (MESO) announces the FDA acceptance for review of the resubmitted biological license application for remestemcel-L for the treatment of children under 12 with steroid-refractory acute graft versus...

INCY : 53.06 (-0.82%)
ADMA : 8.81 (+27.13%)
MESO : 7.36 (+2.65%)
ALLO : 2.76 (-3.50%)
Mesoblast Limited (MESO) Upgraded to Buy: Here's What You Should Know

Mesoblast Limited (MESO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MESO : 7.36 (+2.65%)
Appendix 4C Quarterly Activity Report

Mesoblast Operational and Financial Highlights for Quarter Ended June 30, 2022...

MSB.AX : 1.065 (-2.29%)
MESO : 7.36 (+2.65%)
Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and Management

NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...

MSB.AX : 1.065 (-2.29%)
MESO : 7.36 (+2.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mesoblast Limited is a global leader in developing innovative cell-based medicines. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late-stage product candidates. Mesoblast's...

See More

Key Turning Points

3rd Resistance Point 7.73
2nd Resistance Point 7.55
1st Resistance Point 7.46
Last Price 7.36
1st Support Level 7.19
2nd Support Level 7.01
3rd Support Level 6.92

See More

52-Week High 10.24
Last Price 7.36
Fibonacci 61.8% 6.94
Fibonacci 50% 5.92
Fibonacci 38.2% 4.91
52-Week Low 1.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar